Michael P Busch Selected Research

amotosalen

1/2022	Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment.
1/2022	Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reduction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael P Busch Research Topics

Disease

105	Infections 10/2023 - 07/2002
34	Viremia 11/2020 - 03/2003
25	HIV Infections (HIV Infection) 10/2023 - 05/2002
21	COVID-19 04/2024 - 01/2020
13	West Nile Fever 10/2023 - 08/2005
10	Hemolysis 03/2024 - 01/2019
7	Zika Virus Infection 01/2022 - 01/2017
7	Transfusion-Related Acute Lung Injury 10/2011 - 02/2009
5	Persistent Infection 01/2016 - 10/2007
4	Reinfection 03/2024 - 02/2013
4	Dengue (Dengue Fever) 01/2022 - 01/2016
4	Inflammation (Inflammations) 12/2021 - 08/2013
4	Iron Deficiencies 01/2021 - 02/2012
4	Wounds and Injuries (Trauma) 12/2012 - 10/2004
3	Glucosephosphate Dehydrogenase Deficiency 12/2022 - 01/2021
3	Chagas Disease (American Trypanosomiasis) 02/2021 - 12/2010
3	Flavivirus Infections 01/2021 - 09/2005
3	HIV Seropositivity 12/2016 - 03/2006
3	Hepatitis B 03/2014 - 08/2004
3	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 09/2005 - 09/2004
2	Transfusion Reaction 01/2024 - 11/2004
2	Critical Illness (Critically Ill) 01/2024 - 11/2023
2	Hepatitis 10/2023 - 03/2003
2	Neoplasms (Cancer) 01/2023 - 01/2013
2	Convalescence 02/2022 - 01/2021
2	Hepatitis C 01/2022 - 09/2011
2	Virus Diseases (Viral Diseases) 01/2022 - 11/2003
2	Cough 07/2021 - 03/2021
2	Fever (Fevers) 07/2021 - 03/2021
2	Restless Legs Syndrome (Restless Legs) 01/2021 - 01/2019
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 11/2017
2	Infertility (Sterility) 01/2020 - 07/2014
2	Breakthrough Infections 01/2019 - 03/2014
2	Parasitemia 12/2018 - 11/2018
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 11/2016
2	Asymptomatic Infections 06/2016 - 07/2003
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2012 - 07/2003
2	Chronic Hepatitis C 07/2012 - 07/2010
1	Chronic Disease (Chronic Diseases) 03/2024
1	Obesity 03/2024
1	Hypoxia (Hypoxemia) 01/2024
1	Thrombosis (Thrombus) 12/2023
1	Communicable Diseases (Infectious Diseases) 10/2023

Drug/Important Bio-Agent (IBA)

45	RNA (Ribonucleic Acid)IBA 03/2024 - 05/2002
36	AntibodiesIBA 12/2023 - 07/2006
21	Immunoglobulin G (IgG)IBA 03/2024 - 09/2005
20	VaccinesIBA 12/2023 - 11/2006
20	AntigensIBA 02/2021 - 05/2002
19	Nucleic AcidsIBA 01/2022 - 04/2003
17	Immunoglobulin M (IgM)IBA 01/2021 - 08/2005
15	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 05/2002
13	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2004
13	N-acetyltalosaminuronic acid (NAT)IBA 10/2022 - 08/2003
12	EnzymesIBA 01/2021 - 05/2002
9	Neutralizing AntibodiesIBA 01/2022 - 01/2020
8	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2003
5	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2012
5	IronIBA 01/2021 - 02/2012
5	InterferonsIBA 07/2020 - 10/2008
4	Oxygen (Dioxygen)IBA 01/2024 - 03/2021
4	Peptides (Polypeptides)IBA 01/2022 - 12/2003
4	CytokinesIBA 07/2020 - 08/2006
4	Interleukin-10 (Interleukin 10)IBA 03/2014 - 08/2006
4	HLA Antigens (Human Leukocyte Antigens)IBA 04/2011 - 02/2009
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2006 - 06/2003
3	Hemoglobins (Hemoglobin)IBA 01/2024 - 11/2022
3	HIV AntibodiesIBA 09/2019 - 01/2010
3	AIDS VaccinesIBA 01/2019 - 11/2006
3	InterleukinsIBA 03/2014 - 08/2012
2	LipidsIBA 03/2024 - 01/2021
2	Blood Group Antigens (Blood Groups)IBA 01/2024 - 01/2016
2	BilirubinIBA 11/2023 - 11/2022
2	InflammasomesIBA 01/2023 - 01/2012
2	COVID-19 VaccinesIBA 11/2022 - 01/2022
2	amotosalenIBA 01/2022 - 01/2022
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 01/2021
2	benzonidazole (benznidazole)IBA 02/2021 - 11/2018
2	NucleoproteinsIBA 01/2021 - 05/2020
2	Interferon LambdaIBA 12/2020 - 11/2020
2	Viral RNAIBA 12/2020 - 04/2009
2	Hormones (Hormone)IBA 01/2019 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 09/2011
2	Interleukin-13IBA 12/2012 - 08/2006
2	ChemokinesIBA 09/2011 - 10/2008
2	HLA-DR Antigens (HLA-DR)IBA 04/2011 - 01/2011
1	CholesterolIBA 04/2024
1	Carnitine (L-Carnitine)FDA LinkGeneric 03/2024
1	HypoxanthineIBA 01/2024
1	Adenosine Triphosphate (ATP)IBA 01/2024
1	2,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA 01/2024
1	KynurenineIBA 11/2023
1	Large Neutral Amino Acid-Transporter 1IBA 11/2023

Therapy/Procedure

16	Therapeutics 11/2021 - 07/2002
9	Blood Transfusion (Blood Transfusions) 10/2023 - 10/2004
8	Art Therapy 10/2022 - 03/2006
6	Donor Selection 01/2024 - 03/2006
6	Highly Active Antiretroviral Therapy (HAART) 03/2014 - 07/2003
4	Blood Component Removal (Apheresis) 01/2020 - 02/2008
3	Immunotherapy 01/2022 - 01/2016
1	Platelet Transfusion (Blood Platelet Transfusions) 12/2023